Year: 2018
Type: review
Abstract: We discuss the current status of liquid biopsy and its advantages and challenges with a focus on pre-analytical sample handling, technologies and workflows. The potential of circulating tumor cells and circulating tumor DNA is pointed out and an overview of corresponding technologies is given.
Institution: Bayer (Germany)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,230
Awards: G1790409981, G3207356259
OpenAlex ID: W2807613611
